Isoacteoside alleviates hepatocellular carcinoma progression by inhibiting PDHB-mediated reprogramming of glucose metabolismLijun Zhao(Xinxiang Medical University), Xiangpeng Wang(Xinxiang Medical University)Communications BiologyFebruary 8, 202510.1038/s42003-025-07622-xCited by 11SaveCiteExport RISWatch citationsRelated PapersEpithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets|MedComm|2024|21Network Models of Prostate Cancer Immune Microenvironments Identify ROMO1 as Heterogeneity and Prognostic Marker|Research Square|2021|0